Balentine LLC’s iShares Biotechnology ETF IBB Stock Holding History

Balentine LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12	Closed	-$1.75K	–	203
2024 Q3	$1.75K	Hold	12	–	–	﹤0.01%	213
2024 Q2	$1.65K	Hold	12	–	–	﹤0.01%	181
2024 Q1	$1.65K	Hold	12	–	–	﹤0.01%	581
2023 Q4	$1.63K	Hold	12	–	–	﹤0.01%	570
2023 Q3	$1.47K	Sell	12 -14	-54%	-$1.78K	﹤0.01%	550
2023 Q2	$3.3K	Buy	26 +14	+117%	+$1.82K	﹤0.01%	552
2023 Q1	$1.55K	Hold	12	–	–	﹤0.01%	597
2022 Q4	$1.57K	Sell	12 -5	-29%	-$646	﹤0.01%	635
2022 Q3	$2K	Hold	17	–	–	﹤0.01%	584
2022 Q2	$2K	Hold	17	–	–	﹤0.01%	618
2022 Q1	$2K	Hold	17	–	–	﹤0.01%	617
2021 Q4	$3K	Hold	17	–	–	﹤0.01%	412
2021 Q3	$3K	Hold	17	–	–	﹤0.01%	309
2021 Q2	$3K	Sell	17 -40	-70%	-$6.16K	﹤0.01%	212
2021 Q1	$9K	Buy	57 +40	+235%	+$6.35K	﹤0.01%	195
2020 Q4	$3K	Hold	17	–	–	﹤0.01%	166
2020 Q3	$2K	Buy	+17	New	+$2.31K	﹤0.01%	141
2018 Q1	–	Sell	-72	Closed	-$23K	–	262
2017 Q4	$23K	Sell	72 -144	-67%	-$15.4K	﹤0.01%	363
2017 Q3	$24K	Hold	216	–	–	﹤0.01%	366
2017 Q2	$22K	Hold	216	–	–	﹤0.01%	358
2017 Q1	$21K	Hold	216	–	–	﹤0.01%	339
2016 Q4	$19K	Hold	216	–	–	﹤0.01%	333
2016 Q3	$21K	Hold	216	–	–	﹤0.01%	274
2016 Q2	$19K	Buy	+216	New	+$19.4K	﹤0.01%	255

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Balentine LLC's IBB Position: Q4 2024 in Review

Balentine LLC sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 12 shares — an estimated $1.75K sold.

Balentine LLC first reported a position in IBB in Q2 2016 and held it in 24 quarters. The position peaked at $24K in Q3 2017. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Balentine LLC reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Balentine LLC sold 12 iShares Biotechnology ETF shares in Q4 2024, an estimated $1.75K.
Balentine LLC first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 24 quarters.
Balentine LLC's iShares Biotechnology ETF position peaked at $24K in Q3 2017.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Balentine LLC's 13F filing for Q4 2024, filed 29 Jan 2025.